Duke University

Grantee Website Durham, North Carolina, United States
Purpose
to develop dimimeric IgA human monoclonal antibodies as passive therapy for HIV-1 prevention
Division
Global Health
Year Awarded
2012
Region Served
GLOBAL
Committed Amount
$8,900,481
Grant Topic
HIV
Duration (Months)
44
Grantee Location
Durham, North Carolina, United States

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.